|
End-of-day quote
NSE India S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 134.65 INR | +5.00% |
|
+12.40% | +92.36% |
Company Valuation: Valiant Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2024 | 2025 | 2026 |
|---|---|---|---|
| Market Cap 1 | 6,302 | 3,327 | 2,804 |
| Change | - | -47.2% | -15.74% |
| Enterprise Value (EV) 1 | 5,631 | 3,780 | 2,934 |
| Change | - | -32.87% | -22.38% |
| P/E | 1,725x | -150x | -79.4x |
| PBR | 2.66x | 1.42x | 0.9x |
| PEG | -17.4x | 0x | -2.9x |
| Capitalization / Revenue | 3.46x | 2.49x | 1.18x |
| EV / Revenue | 3.09x | 2.83x | 1.24x |
| EV / EBITDA | -65.5x | -77.6x | 43.2x |
| EV / EBIT | -54.3x | -55.8x | 303x |
| EV / FCF | -14.1x | -2.79x | -6.1x |
| FCF Yield | -7.11% | -35.9% | -16.4% |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | 0.0841 | -0.51 | -0.65 |
| Distribution rate | - | - | - |
| Net sales 1 | 1,821 | 1,334 | 2,375 |
| EBITDA 1 | -85.98 | -48.7 | 67.99 |
| EBIT 1 | -103.7 | -67.72 | 9.695 |
| Net income 1 | 3.196 | -22.01 | -32.68 |
| Net Debt 1 | -671.1 | 452.9 | 130.6 |
| Reference price 2 | 145.05 | 76.58 | 51.62 |
| Nbr of stocks (in thousands) | 43,450 | 43,450 | 54,313 |
| Announcement Date | 7/17/24 | 9/1/25 | 9/3/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 77.06M | ||
| 37.94x | 5.18x | 20.99x | 1.02% | 80.98B | ||
| 33.68x | 5.12x | 21.82x | 1.89% | 43.87B | ||
| 24.74x | 2.93x | 15.26x | 2.11% | 35.55B | ||
| 15.47x | 1.6x | 8.91x | 2.7% | 33.94B | ||
| 38.45x | 6.96x | 18.46x | 1.6% | 31.89B | ||
| 14.61x | 1.4x | 8.64x | 2.18% | 25.99B | ||
| 41.16x | 10.09x | 30.53x | 2.13% | 25.11B | ||
| 24.49x | 2.65x | 10.77x | 1.84% | 17.62B | ||
| 8.17x | 2.28x | 4.54x | 3.19% | 17.2B | ||
| Average | 26.52x | 4.24x | 15.55x | 2.07% | 31.22B | |
| Weighted average by Cap. | 29.37x | 4.48x | 17.14x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VALIANTLAB Stock
- Valuation Valiant Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















